Medical Microinstruments, Inc. (MMI) is a fast-growing surgical robotics company that develops and commercializes robotic-assisted microsurgery systems. Their flagship product, the Symani Surgical System, features the world's smallest wristed instruments and is designed for robotic-assisted microsurgery and supermicrosurgery.

Medical Microinstruments, Inc. (MMI)

A developer of novel robotic solutions for unmet medical needs for microsurgery.

MMI has developed the first teleoperated robotic platform for suturing in open surgery with wristed microinstruments. It offers the surgeon motion scaling and tremor elimination and aims to facilitate existing procedures as well as enable new ones in the domain of microsurgery, from post-oncological and trauma reconstructions to ophthalmology, organ transplantation and pediatric surgery. 

The Company’s mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large.

Panakes Partners

Andera Partners

Fountain Healthcare Partners

BioStar Capital

Samba Tech

RA Capital Management

Deerfield

Fidelity

Medical Microinstruments, Inc.

The next great breakthrough in microsurgery is now available in the U.S.! The FDA has authorized the Symani Surgical System for commercial use. This game-changing, robotic technology increases patient access to advanced techniques for surgeries in complex disease states and provides surgeons with enhanced precision and control.   

Learn more about the first microsurgical robotic platform available in the U.S.: https://lnkd.in/ehxdQgVc

#Symani #microsurgery #robotics 

Surgeons have leveraged the Symani Surgical System in countless clinical cases in the European Union and in many preclinical cases around the world. To learn more about some of the research that’s been performed using the system, visit our website: https://ow.ly/Tbt050R7lpo

#roboticsurgery #microsurgery

The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S.

As Lymphedema Awareness Month comes to a close, we remain proud to support Lymphatic Education & Research Network and its vital mission to fight lymphatic diseases through education, research and advocacy. For patients suffering from lymphatic diseases, LE&RN’s online resource center offers valuable insights into treatment options and specialized #lymphatic centers. We’re excited to partner with LE&RN to continue to raise awareness and support for lymphatic diseases. 

Learn more:  https://lnkd.in/g92Qy5xE

Thank you to Italian Tech Alliance for conducting a study – and including MMI – about the positive impact startup companies are having on local employment growth. We're honored Deborah Lo Conti, Sr. HR Generalist, was invited to participate in yesterday's panel discussion. We are proud to support job creation in our communities!

We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. Learn more about our mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore the quality of life for patients with complex conditions: https://lnkd.in/ezR8AxjV
 
#robotics #microsurgery #Symani
 
The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S. 

COM:MMIMICRO

Medical Microinstruments, Inc. (MMI)